UY37100A - Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas - Google Patents

Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas

Info

Publication number
UY37100A
UY37100A UY0001037100A UY37100A UY37100A UY 37100 A UY37100 A UY 37100A UY 0001037100 A UY0001037100 A UY 0001037100A UY 37100 A UY37100 A UY 37100A UY 37100 A UY37100 A UY 37100A
Authority
UY
Uruguay
Prior art keywords
vectorized
fmdv
same
recombinant adenovirus
fmdv vaccines
Prior art date
Application number
UY0001037100A
Other languages
English (en)
Inventor
Justin Widener
Leszlie Woodyward
Leonardo Siger
Douglas Brough
Damodar Ettyreddy
Jason Gall
Duncan McVEY
Tom Burrage
John Schutta Christopher
Original Assignee
Merial Inc
Genvec Inc
The Government Of The Us Secretary Of Homeland Security
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc, Genvec Inc, The Government Of The Us Secretary Of Homeland Security filed Critical Merial Inc
Publication of UY37100A publication Critical patent/UY37100A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención abarca vacunas o composiciones de FMDV. Se describen vectores recombinantes que codifican y que expresan antígenos, epitopes o inmunógenos de FMDV que se pueden usar para proteger animales, en particular ovinos, bovinos, caprinos, o porcinos, contra el FMDV.
UY0001037100A 2016-01-29 2017-01-30 Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas UY37100A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662288540P 2016-01-29 2016-01-29

Publications (1)

Publication Number Publication Date
UY37100A true UY37100A (es) 2017-08-31

Family

ID=58191570

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037100A UY37100A (es) 2016-01-29 2017-01-30 Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas

Country Status (22)

Country Link
US (2) US10188721B2 (es)
EP (1) EP3408398B1 (es)
JP (1) JP6878464B2 (es)
KR (1) KR102283303B1 (es)
CN (1) CN108779474B (es)
AR (1) AR110458A1 (es)
AU (1) AU2017212813B2 (es)
BR (1) BR112018015345A8 (es)
CA (1) CA3012802A1 (es)
CY (1) CY1124218T1 (es)
DK (1) DK3408398T3 (es)
ES (1) ES2787902T3 (es)
JO (1) JOP20170022B1 (es)
MA (1) MA43195B1 (es)
MX (1) MX2018009244A (es)
NZ (1) NZ744786A (es)
PT (1) PT3408398T (es)
RU (1) RU2725495C9 (es)
TW (1) TWI760322B (es)
UY (1) UY37100A (es)
WO (1) WO2017132666A1 (es)
ZA (1) ZA201804965B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI760322B (zh) * 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
CN108997493B (zh) * 2018-08-15 2019-07-09 中国农业科学院兰州兽医研究所 一种全牛源o型口蹄疫病毒广谱中和抗体的制备方法
US11582956B2 (en) * 2018-09-27 2023-02-21 The United States Of America, As Represented By The Secretary Of Agriculture Recombinant adenovirus-based interferon biotherapeutics in swine
CN113817068B (zh) * 2020-12-24 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的o型口蹄疫疫苗
CN114957480B (zh) * 2021-02-23 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的a型口蹄疫疫苗
CN112852760A (zh) * 2021-03-04 2021-05-28 温氏食品集团股份有限公司 重组鸭肠炎病毒及其应用
US20230149528A1 (en) * 2021-08-18 2023-05-18 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype o
WO2023090771A1 (ko) * 2021-11-17 2023-05-25 대한민국(농림축산식품부 농림축산검역본부장) 강력한 적응성 면역반응 유도 및 모체이행항체의 간섭을 극복하는 재조합 구제역 o형 바이러스 및 이를 포함하는 구제역 백신 조성물
KR20240098951A (ko) 2022-12-21 2024-06-28 대한민국(농림축산식품부 농림축산검역본부장) 초기 방어가 가능한 피내접종용 구제역 백신 조성물
KR20240098948A (ko) 2022-12-21 2024-06-28 대한민국(농림축산식품부 농림축산검역본부장) 장기 면역 유도가 가능한 피내접종용 구제역 백신 조성물
KR20240098952A (ko) 2022-12-21 2024-06-28 대한민국(농림축산식품부 농림축산검역본부장) 구제역백신의 무침 피내 접종방법

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
EP0138854B1 (en) 1983-03-08 1992-11-04 Chiron Mimotopes Pty. Ltd. Antigenically active amino acid sequences
EP0173552B1 (en) 1984-08-24 1991-10-09 The Upjohn Company Recombinant dna compounds and the expression of polypeptides such as tpa
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US4963481A (en) 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
IE872455L (en) 1986-09-12 1988-03-12 Lanstrase Ltd Improved recombinant expression
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3743138A1 (de) 1987-12-18 1989-09-14 Mayr Christian Gmbh & Co Kg Schleifringlose, elektromagnetische ueberlastkupplung
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
AU672359B2 (en) 1991-03-07 1996-10-03 Virogenetics Corporation Genetically engineered vaccine strain
CA2214029A1 (en) 1995-04-25 1996-10-31 Magda Marquet Single-vial formulations of dna/lipid complexes
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
ATE292980T1 (de) 1996-10-11 2005-04-15 Univ California Immunostimulierende oligonucleotidekonjugate
DE69826124T3 (de) 1997-06-30 2007-10-11 Institut Gustave Roussy Verabreichung der nukleinsäure in den quergestreiften muskel
FR2778858B1 (fr) 1998-05-20 2000-06-16 Oreal Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
FR2801607B1 (fr) 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
FR2810888B1 (fr) 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
RU2294211C2 (ru) * 2001-01-19 2007-02-27 Цитос Байотекнолоджи Аг Композиция и способ для иммунизации, способ продуцирования неприродного, упорядоченного и повторяющегося массива антигенов
WO2005009462A2 (en) 2003-07-24 2005-02-03 Merial Limited Vaccine formulations comprising an oil-in-water emulsion
BRPI0512421B8 (pt) * 2004-06-25 2022-06-28 Merial Ltd Recombinantes de avipox expressando genes do vírus da doença febre aftosa
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
CA2629163C (en) * 2005-11-10 2017-03-21 Genvec, Inc. Adenoviral vector-based foot-and-mouth disease vaccine
SI2475384T1 (sl) 2009-09-10 2016-12-30 Merial, Inc. Nove formulacije cepiva, ki obsegajo adjuvante, vsebujoče saponin
BR112012023852B1 (pt) * 2010-03-12 2020-11-10 Biolex Therapeutics vacinas recombinantes do vírus da língua azul e usos das mesmas
US8765141B2 (en) * 2010-07-01 2014-07-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
CN107073100B (zh) 2014-09-23 2021-02-26 勃林格殷格翰动物保健美国公司 Fmdv重组疫苗及其用途
TWI760322B (zh) * 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途

Also Published As

Publication number Publication date
CA3012802A1 (en) 2017-08-03
TW201735944A (zh) 2017-10-16
AU2017212813B2 (en) 2020-10-08
EP3408398B1 (en) 2019-11-27
JOP20170022B1 (ar) 2021-08-17
WO2017132666A1 (en) 2017-08-03
MA43195A1 (fr) 2019-04-30
US20170216422A1 (en) 2017-08-03
ES2787902T3 (es) 2020-10-19
TWI760322B (zh) 2022-04-11
NZ744786A (en) 2020-05-29
KR102283303B1 (ko) 2021-07-28
RU2018130813A (ru) 2020-03-03
MA43195B1 (fr) 2020-11-30
US10188721B2 (en) 2019-01-29
AU2017212813A1 (en) 2018-08-16
BR112018015345A2 (pt) 2018-12-18
AR110458A1 (es) 2019-04-03
CY1124218T1 (el) 2022-11-25
JP2019507184A (ja) 2019-03-14
MX2018009244A (es) 2019-07-10
EP3408398A1 (en) 2018-12-05
US20190134183A1 (en) 2019-05-09
CN108779474A (zh) 2018-11-09
RU2725495C9 (ru) 2020-09-01
DK3408398T3 (da) 2020-02-10
PT3408398T (pt) 2020-02-25
KR20180121896A (ko) 2018-11-09
CN108779474B (zh) 2022-10-18
BR112018015345A8 (pt) 2022-06-28
RU2725495C2 (ru) 2020-07-02
US10493144B2 (en) 2019-12-03
ZA201804965B (en) 2019-07-31
JP6878464B2 (ja) 2021-05-26
RU2018130813A3 (es) 2020-03-03

Similar Documents

Publication Publication Date Title
UY37100A (es) Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas
BR112017005833A2 (pt) vacinas recombinantes fmdv e seus usos
CO2018004564A2 (es) Genes de ataxia de friedreich modificados y vectores para terapia génica
ES2981730T3 (es) Agentes terapéuticos dirigidos y usos de los mismos
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
EA201790294A1 (ru) Средства на основе флагеллина и применения, включающие эффективную вакцинацию
AR102657A1 (es) Composición para tratar telas
AR105470A1 (es) Métodos para inducir una respuesta inmune
BR112019010275A2 (pt) adenovírus recombinante, composição, uso do adenovírus ou composição, método de induzir uma resposta imune em um paciente, e, adenovírus de símio não humano
UY36995A (es) Proteínas de fusión de e2 y fmdv y sus usos
ECSP19008417A (es) Anticuerpos con inmunogenicidad baja y usos de estos
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
PE20190397A1 (es) Virus de enteritis de pato y usos del mismo
CL2019000032A1 (es) Uso de oxido de aleno sintasa para la preservación de semen y la reproducción asistida (divisional solicitud 201603067)
PE20181158A1 (es) Vacunacion con el dominio alfa 3 de mica/b para el tratamiento del cancer
CL2016001906A1 (es) Vacunas contra el reovirus aviar.
UY36328A (es) Vacunas de fmdv recombinante y usos de las mismas
NZ734938A (en) Leptospira immunoprotective proteins and methods of identification and use thereof
EA202090236A1 (ru) Иммуногенные композиции senecavirus a и способы с ними
UY36860A (es) Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos
AR095501A1 (es) Vacunas rsv
CL2014000794A1 (es) Formulacion inmunogenica de proteinas de flavobacterium psychrophilum y lipopolisacaridos de e. coli, efectiva en la proteccion de peces contra flavobacterium; vacuna recombinante que comprende la formulación; procedimiento para preparar la formulación; proteina inmunogénica de flavobacterium psychrophilum.

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20240201